Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Polarized localization of phosphatidylserine in the endothelium regulates Kir2.1
Claire A. Ruddiman, … , Jessica E. Wagenseil, Brant E. Isakson
Claire A. Ruddiman, … , Jessica E. Wagenseil, Brant E. Isakson
Published April 4, 2023
Citation Information: JCI Insight. 2023;8(9):e165715. https://doi.org/10.1172/jci.insight.165715.
View: Text | PDF
Research Article Vascular biology

Polarized localization of phosphatidylserine in the endothelium regulates Kir2.1

  • Text
  • PDF
Abstract

Lipid regulation of ion channels is largely explored using in silico modeling with minimal experimentation in intact tissue; thus, the functional consequences of these predicted lipid-channel interactions within native cellular environments remain elusive. The goal of this study is to investigate how lipid regulation of endothelial Kir2.1 — an inwardly rectifying potassium channel that regulates membrane hyperpolarization — contributes to vasodilation in resistance arteries. First, we show that phosphatidylserine (PS) localizes to a specific subpopulation of myoendothelial junctions (MEJs), crucial signaling microdomains that regulate vasodilation in resistance arteries, and in silico data have implied that PS may compete with phosphatidylinositol 4,5-bisphosphate (PIP2) binding on Kir2.1. We found that Kir2.1-MEJs also contained PS, possibly indicating an interaction where PS regulates Kir2.1. Electrophysiology experiments on HEK cells demonstrate that PS blocks PIP2 activation of Kir2.1 and that addition of exogenous PS blocks PIP2-mediated Kir2.1 vasodilation in resistance arteries. Using a mouse model lacking canonical MEJs in resistance arteries (Elnfl/fl/Cdh5-Cre), PS localization in endothelium was disrupted and PIP2 activation of Kir2.1 was significantly increased. Taken together, our data suggest that PS enrichment to MEJs inhibits PIP2-mediated activation of Kir2.1 to tightly regulate changes in arterial diameter, and they demonstrate that the intracellular lipid localization within the endothelium is an important determinant of vascular function.

Authors

Claire A. Ruddiman, Richard Peckham, Melissa A. Luse, Yen-Lin Chen, Maniselvan Kuppusamy, Bruce A. Corliss, P. Jordan Hall, Chien-Jung Lin, Shayn M. Peirce, Swapnil K. Sonkusare, Robert P. Mecham, Jessica E. Wagenseil, Brant E. Isakson

×

Figure 6

Elnfl/fl/Cre+ mice have disrupted PS localization in endothelium.

Options: View larger image (or click on image) Download as PowerPoint

Elnfl/fl/Cre+ mice have disrupted PS localization in endothelium.
(A) G...
(A) Genomic DNA (gDNA) isolated from EC-rich lung tissue demonstrating expected excision band of elastin in Elnfl/fl/Cre+ tissue at 410 bp. (B) qPCR on mesenteric vasculature to quantify mRNA levels of Eln for the 2 genotypes Elnfl/fl/Cre– and Elnfl/fl/Cre+. n = 6–9 mice per group. Student’s t test; ***P = 0.0001. (C) Paraffin cross-sections of third-order mesenteric arteries stained with Verhoeff elastic stain (black) and van Gieson (pink), where the asterisk indicates lumen. Scale bar: 30 μm. Quantification of percent area occupied by Verhoeff stain on the right. n = 5–6 mice per group. Student’s t test; *P < 0.05. (D and E) En face IHC on Elnfl/fl/Cre– and Elnfl/fl/Cre+ third-order mesenteric arteries where interendothelial junctions (green) are detected via claudin-5, nuclei (blue) are detected via DAPI, and IEL (gray) is detected via and Alexa Fluor 488–linked hydrazide. Scale bar: 30 μm. (F) Quantification of IEL area in en face views, expressed as a percentage of total image area. n = 5 mice, n = 5–6 arteries. Student’s t test; ****P < 0.0001. (G and H) En face IHC on Elnfl/fl/Cre– and Elnfl/fl/Cre+ third-order mesenteric arteries where PS (magenta) and nuclei (blue) are detected via DAPI and IEL (gray) is detected via Alexa Fluor 488–linked hydrazide. PS heatmaps were generated using Royal Lookup Tables in ImageJ, where low-intensity signal is in cool tones (blue to cyan) and high-intensity signal is warm tones (yellow to white). The white box on the heatmap indicates the zoomed-in area shown to the right. Scale bars: 10 μm. (I–L) Quantification of PS area, puncta size, low-intensity pixels, and high-intensity pixels in PS en face images comparing Elnfl/fl/Cre– and Elnfl/fl/Cre+ third-order mesenteric arteries. n = 3–4 mice, and n = 4–5 arteries per group. Student’s t test; *P < 0.05.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts